Shaoxi Niu

681 total citations
20 papers, 181 citations indexed

About

Shaoxi Niu is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Shaoxi Niu has authored 20 papers receiving a total of 181 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 6 papers in Molecular Biology and 6 papers in Cancer Research. Recurrent topics in Shaoxi Niu's work include Prostate Cancer Treatment and Research (9 papers), Prostate Cancer Diagnosis and Treatment (7 papers) and Renal cell carcinoma treatment (4 papers). Shaoxi Niu is often cited by papers focused on Prostate Cancer Treatment and Research (9 papers), Prostate Cancer Diagnosis and Treatment (7 papers) and Renal cell carcinoma treatment (4 papers). Shaoxi Niu collaborates with scholars based in China, Italy and Taiwan. Shaoxi Niu's co-authors include Xin Ma, Yu Gao, Huijie Gong, Liangyou Gu, Qingbo Huang, Hongzhao Li, Xintao Li, Fan Yang, Yu Zhang and Xu Zhang and has published in prestigious journals such as Clinical Cancer Research, The Journal of Urology and Cell Death and Disease.

In The Last Decade

Shaoxi Niu

18 papers receiving 180 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shaoxi Niu China 7 89 75 51 33 25 20 181
Ze-Ning Huang China 10 152 1.7× 57 0.8× 27 0.5× 73 2.2× 55 2.2× 28 269
Joshua Kapp Switzerland 9 156 1.8× 70 0.9× 96 1.9× 75 2.3× 84 3.4× 14 269
Victoria Arthur United States 4 109 1.2× 62 0.8× 54 1.1× 13 0.4× 33 1.3× 8 201
Diederik Wehkamp Netherlands 7 20 0.2× 88 1.2× 74 1.5× 69 2.1× 24 1.0× 11 272
Hermioni Zouridis United States 4 43 0.5× 253 3.4× 60 1.2× 61 1.8× 43 1.7× 5 312
Fangyan Yu United States 10 31 0.3× 130 1.7× 131 2.6× 61 1.8× 10 0.4× 16 240
Deborah R. Smith United States 7 64 0.7× 77 1.0× 13 0.3× 32 1.0× 10 0.4× 15 204
Kevin Huang United States 8 56 0.6× 91 1.2× 44 0.9× 44 1.3× 21 0.8× 10 226
Shusuan Jiang China 9 99 1.1× 66 0.9× 54 1.1× 43 1.3× 42 1.7× 27 213

Countries citing papers authored by Shaoxi Niu

Since Specialization
Citations

This map shows the geographic impact of Shaoxi Niu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shaoxi Niu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shaoxi Niu more than expected).

Fields of papers citing papers by Shaoxi Niu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shaoxi Niu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shaoxi Niu. The network helps show where Shaoxi Niu may publish in the future.

Co-authorship network of co-authors of Shaoxi Niu

This figure shows the co-authorship network connecting the top 25 collaborators of Shaoxi Niu. A scholar is included among the top collaborators of Shaoxi Niu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shaoxi Niu. Shaoxi Niu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Niu, Shaoxi, et al.. (2024). Suitability of the MP1000 Platform for Robot-assisted Prostatectomy: A Prospective Randomised Controlled Trial. European Urology Open Science. 64. 2–8. 3 indexed citations
2.
3.
Niu, Shaoxi, Xiaojun Zhang, Huanhuan Liu, et al.. (2024). Real-time diagnosis of sampled lesions in targeted biopsy of prostate Cancer using a novel tracer [64Cu] Cu-DOTA-PSMA-3Q: a pilot preclinical study. European Journal of Nuclear Medicine and Molecular Imaging. 52(4). 1257–1270. 3 indexed citations
4.
Gao, Yu, Yang Yang, Shaoxi Niu, et al.. (2024). Suitability of the MP1000 system for robot-assisted partial nephrectomy: a multicenter randomized controlled noninferiority trial. International Journal of Surgery. 110(5). 2803–2809. 7 indexed citations
5.
Niu, Shaoxi, Xiaojun Zhang, Xiaodan Xu, et al.. (2024). The first-in-human preclinical evaluation of the new probe [123I]I-PSMA-7 for real-time intraoperative targeted biopsy and SPECT/CT imaging in prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging. 51(13). 4141–4150. 2 indexed citations
6.
7.
8.
Wang, Yunhe, Yundong Xuan, Binbin Su, et al.. (2023). Predicting recurrence and survival in patients with non-metastatic renal-cell carcinoma after nephrectomy: a prospective population-based study with multicenter validation. International Journal of Surgery. 110(2). 820–831. 1 indexed citations
9.
Niu, Shaoxi, Xiaojun Zhang, Jiajin Liu, et al.. (2023). Can 18F-PSMA-7Q PET/CT replace prostate biopsy for the diagnosis of prostate cancer?—A single-center retrospective study. Translational Andrology and Urology. 12(1). 83–89. 3 indexed citations
10.
Olivero, Alberto, Kan Liu, Lulin Ma, et al.. (2023). Adrenocortical carcinoma with venous tumor invasion: is there a role for mini-invasive surgery?. Langenbeck s Archives of Surgery. 408(1). 17–17. 2 indexed citations
11.
Gao, Yu, Yang Yang, Xing Li, et al.. (2023). Vesicoprostatic muscle reconstruction: a step further for immediate and early urinary continence. World Journal of Urology. 41(6). 1511–1517.
12.
Yang, Qian, Qiuyang Li, Nan Li, et al.. (2023). Radiotranscriptomics identified new mRNAs and miRNA markers for distinguishing prostate cancer from benign prostatic hyperplasia. Cancer Medicine. 12(24). 21694–21708. 4 indexed citations
13.
Niu, Shaoxi, Xiaohui Ding, Yong Xu, et al.. (2022). 18F‐DCFPyL positron emission tomography/magnetic resonance imaging‐guided ultrasound fusion biopsy is an identical pathway in prostate cancer diagnosis. The Prostate. 83(2). 142–150. 3 indexed citations
14.
Zhu, Yumeng, Yang Wang, Yongbo Pan, et al.. (2022). DMDRMR promotes angiogenesis via antagonizing DAB2IP in clear cell renal cell carcinoma. Cell Death and Disease. 13(5). 456–456. 19 indexed citations
15.
Yang, Bo, Xiao Zhao, Chong Wan, et al.. (2021). Genomic profiling of Chinese patients with urothelial carcinoma. BMC Cancer. 21(1). 162–162. 6 indexed citations
16.
17.
Liu, Yen‐Nien, Shaoxi Niu, Wei‐Yu Chen, et al.. (2019). Leukemia Inhibitory Factor Promotes Castration-resistant Prostate Cancer and Neuroendocrine Differentiation by Activated ZBTB46. Clinical Cancer Research. 25(13). 4128–4140. 39 indexed citations
18.
Yao, Yuanxin, Huijie Gong, Liangyou Gu, et al.. (2019). Risk Factors Influencing the Thickness and Stranding of Perinephric Fat of Mayo Adhesive Probability Score in Minimally Invasive Nephrectomy. Medical Science Monitor. 25. 3825–3831. 18 indexed citations
19.
Ma, Xin, Liangyou Gu, Hongzhao Li, et al.. (2015). Hypoxia-induced overexpression of stanniocalcin-1 is associated with the metastasis of early stage clear cell renal cell carcinoma. Journal of Translational Medicine. 13(1). 56–56. 51 indexed citations
20.
Niu, Shaoxi, Xin Ma, Yu Zhang, et al.. (2015). [Expression of miR-223 in clear cell renal cell carcinoma and its significance].. PubMed. 35(3). 338–42. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ze-Ning Huang Breakdown of academic impact, for papers by Joshua Kapp Breakdown of academic impact, for papers by Victoria Arthur Breakdown of academic impact, for papers by Diederik Wehkamp Breakdown of academic impact, for papers by Hermioni Zouridis Breakdown of academic impact, for papers by Fangyan Yu Breakdown of academic impact, for papers by Deborah R. Smith Breakdown of academic impact, for papers by Kevin Huang Breakdown of academic impact, for papers by Shusuan Jiang
Rankless by CCL
2026